Ignite Creation Date:
2025-12-24 @ 10:56 PM
Ignite Modification Date:
2026-01-06 @ 11:33 PM
Study NCT ID:
NCT03589469
Status:
COMPLETED
Last Update Posted:
2023-08-29
First Post:
2018-05-04
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Study to Evaluate the Efficacy and Safety of Loncastuximab Tesirine in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma
Sponsor:
ADC Therapeutics S.A.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
ADCT-402-201
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None